Trials / Completed
CompletedNCT02380976
Phase 1 Clinical Trial of DW340 and DW330SR + DW1030 Co-administration in Healthy Male Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (actual)
- Sponsor
- Daewon Pharmaceutical Co., Ltd. · Industry
- Sex
- Male
- Age
- 20 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
A randomized, open-label, single-dose, crossover Phase I Study to investigate the relative bioavailability of DW340 and DW330SR + DW1030 co-administration in healthy male volunteers.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | combination drug: DW330SR, DW1030 | |
| DRUG | DW340 |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2015-10-01
- First posted
- 2015-03-05
- Last updated
- 2016-10-12
Source: ClinicalTrials.gov record NCT02380976. Inclusion in this directory is not an endorsement.